Holen Sie sich die Stockscreener-App
8.35
1.18%
-0.10
Handel nachbörslich:
8.11
-0.24
-2.87%
Schlusskurs vom Vortag:
$8.45
Offen:
$8.56
24-Stunden-Volumen:
538.90K
Relative Volume:
1.61
Marktkapitalisierung:
$217.71M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-3.087
EPS:
-2.7049
Netto-Cashflow:
$-40.45M
1W Leistung:
+19.97%
1M Leistung:
+47.53%
6M Leistung:
-52.61%
1J Leistung:
-14.01%
1-Tages-Spanne:
$8.21
$8.85
1-Wochen-Bereich:
$6.73
$8.85
52-Wochen-Spanne:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Vergleichen Sie CVRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
8.35 | 181.47M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
120.51 | 232.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.65 | 153.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 150.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.53 | 114.55B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.18 | 46.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains? - Yahoo Finance
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
CVRx announces Medicare win for Barostim therapy - MassDevice
CVRx's Barostim Gains Traction as CMS Reimbursement Policies Shift Gears - AInvest
CVRx Soars 20% Amid Regulatory Reimbursement Breakthrough – What's Next for This Medtech Innovator? - AInvest
CVRx Announces Positive News on Outpatient Payment for Barostim - GlobeNewswire
$CVRX stock is up 15% today. Here's what we see in our data. - Quiver Quantitative
How CVRX stock performs during market volatilityFree Top-Rated Stock Analysis - Newser
CVRx, Inc. Announces Positive News on Outpatient Payment for Barostim - MarketScreener
Medicare proposes to maintain payment for CVRx’s Barostim procedure - Investing.com
CVRx Secures Triple Medicare Payment Victory for Barostim: $45K Outpatient Coverage Confirmed - Stock Titan
What makes CVRX stock price move sharplyCapital Safe Smart Trades - beatles.ru
Why CVRx Inc. stock attracts strong analyst attentionFree Wealth-Building Investment Strategies - Newser
How CVRx Inc. stock performs during market volatilityShort Squeeze Radar - Newser
When TFINP stock expected to show significant growthIs CVRX stock a good long term investment optionFree Elite Traders Group - Newser
What makes CVRx Inc. stock price move sharplyFree VIP Investment Strategies - Newser
Why CVRX stock attracts strong analyst attentionDaily Breakout Picks - Newser
CVRx, Inc.'s (NASDAQ:CVRX) P/S Is Still On The Mark Following 25% Share Price Bounce - simplywall.st
CVRx, Inc. (NASDAQ:CVRX) institutional owners may be pleased with recent gains after 24% loss over the past year - simplywall.st
Long Term Trading Analysis for (CVRX) - news.stocktradersdaily.com
Analysts Are Bullish on These Healthcare Stocks: Evaxion Biotech (EVAX), CVRx (CVRX) - The Globe and Mail
Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest
Q2 Earnings Estimate for CVRx Issued By William Blair - Defense World
CVRx (NASDAQ:CVRX) Upgraded at William Blair - Defense World
William Blair Reaffirms Their Buy Rating on CVRx (CVRX) - The Globe and Mail
(CVRX) Trading Signals - news.stocktradersdaily.com
CVRx: A Strategic Buy Amid Overreaction to Near-Term Challenges - AInvest
CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Rhumbline Advisers Buys 2,192 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
(CVRX) Technical Data - news.stocktradersdaily.com
Is CVRx (NASDAQ:CVRX) Weighed On By Its Debt Load? - simplywall.st
How to Take Advantage of moves in (CVRX) - news.stocktradersdaily.com
CVRx downgraded at J.P. Morgan after Q1 sales miss - MSN
Cantor Fitzgerald Comments on CVRx FY2026 Earnings - Defense World
Squarepoint Ops LLC Sells 8,855 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
Two Sigma Investments LP Has $702,000 Holdings in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Top NASDAQ Stocks Kalkine CVRx, Inc. Amid Short Interest Shift - Kalkine Media
Jane Street Group LLC Sells 2,456 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx, Inc. (NASDAQ:CVRX) Shares Purchased by Bank of America Corp DE - Defense World
Short Interest in CVRx, Inc. (NASDAQ:CVRX) Increases By 19.4% - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
CVRx Confirms Directors and Accounting Firm at Meeting - TipRanks
CVRx at William Blair Conference: Strategic Focus on Barostim - Investing.com
CVRx at William Blair Conference: Strategic Focus on Barostim By Investing.com - Investing.com India
Nuveen Asset Management LLC Has $2.01 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Learn to Evaluate (CVRX) using the Charts - news.stocktradersdaily.com
Millennium Management LLC Sells 30,168 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx to Present at the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Medical Device Leader CVRx Showcases Cardiovascular Breakthroughs at Major Growth Conference - Stock Titan
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):